-
January 07, 2013
Last Monday, I asked each of the StreetAuthority stock market strategists to put into writing their assessments of ...
-
December 18, 2012
The market is having a good day so far: the Nasdaq has increased 1.1%; the S&P 500 is trading up 0.8%; and the Dow ...
-
November 20, 2012
There has been little movement in the market so far this morning. The Nasdaq has been relatively flat; the S&P 500 ...
-
November 14, 2012
The Nasdaq has fallen 0.4%, the S&P 500 has declined 0.5% and the Dow is trading down 0.7%, marking a bad morning ...
-
November 01, 2012
The market has been doing well after the morning's trading. The Nasdaq has moved up 1.3%; the S&P 500 has climbed ...
-
October 24, 2012
So far today, the Nasdaq has moved little, the S&P 500 has risen 0.1% and the Dow is up 0.3%. The utilities sector ...
-
October 02, 2012
The Nasdaq is trading up 0.4%, the S&P 500 has climbed 0.1% and the Dow has slipped 0.2% so far today. The utilities ...
-
August 09, 2012
The market is having a bad day so far. The Nasdaq has fallen 0.1%; the S&P 500 has slipped 0.2%; and the Dow is ...
-
June 12, 2012
With the S&P 500 down more than 6% since May 1, the old adage of "sell in May and go away" looks remarkably ...
-
April 25, 2012
The new energy land rush is in full force, this time in the Utica Shale...and there are some smart places to put ...
-
February 02, 2012
The Great Domestic Energy scramble is underway and it’s time to pick the companies that have the best chance ...
-
May 05, 2009
Despite the recession, the pharmaceutical sector continues to show strong year-over-year earnings results and demand ...
-
March 09, 2009
If you're losing sleep over the down economy, these pharmaceutical picks might help you sleep a little easier.
-
October 24, 2008
Fear has created many buying opportunities. We examine three companies that have low value multiples and low entry ...
-
June 26, 2008
Duke has added renewable energy to its power generation portfolio. The company wants to reduce carbon emissions 50% ...
-
July 09, 2007
A look at three mid-cap pharmaceutical companies with three very different approaches to business.
